Derivative Liabilities - Fair Value
Boston Scientific Derivative Liabilities - Fair Value decreased by 6.0% to $1.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.5%, from $1.05B to $1.23B. Over 5 years (FY 2020 to FY 2025), Derivative Liabilities - Fair Value shows relatively stable performance with a 0.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in liabilities suggests unfavorable market movements for the company's hedges, while a decrease indicates a reduction in potential settlement obligations.
Detailed definition
This represents the fair value of derivative financial instruments that are currently in a liability position. These lia...
Peer comparison
Standard for energy companies; peers with similar hedging profiles will show comparable volatility in this line item.
derivative_liabilities_fair_valueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.16B | $1.12B | $1.07B | $1.07B | $966.00M | $942.00M | $1.01B | $1.01B | $1.02B | $977.00M | $1.05B | $986.00M | $974.00M | $1.09B | $990.00M | $1.05B | $1.42B | $1.33B | $1.31B | $1.23B |
| QoQ Change | — | -3.7% | -4.4% | -0.4% | -9.5% | -2.5% | +6.7% | +0.4% | +1.2% | -4.3% | +7.5% | -6.1% | -1.2% | +11.6% | -8.9% | +5.8% | +35.2% | -6.3% | -1.4% | -6.0% |
| YoY Change | — | — | — | — | -16.9% | -15.9% | -6.2% | -5.4% | +5.7% | +3.7% | +4.5% | -2.3% | -4.6% | +11.3% | -5.7% | +6.2% | +45.4% | +22.1% | +32.1% | +17.5% |
Derivative Liabilities - Fair Value at Other Companies
Frequently Asked Questions
- What is Boston Scientific's derivative liabilities - fair value?
- Boston Scientific (BSX) reported derivative liabilities - fair value of $1.23B in Q1 2026.
- How has Boston Scientific's derivative liabilities - fair value changed year-over-year?
- Boston Scientific's derivative liabilities - fair value increased by 17.5% year-over-year, from $1.05B to $1.23B.
- What is the long-term trend for Boston Scientific's derivative liabilities - fair value?
- Over 5 years (2020 to 2025), Boston Scientific's derivative liabilities - fair value has grown at a 0.7% compound annual growth rate (CAGR), from $1.26B to $1.31B.
- What does derivative liabilities - fair value mean?
- The total market value of all derivative contracts that are currently resulting in a loss.